<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">The Clinician</journal-id><journal-title-group><journal-title xml:lang="en">The Clinician</journal-title><trans-title-group xml:lang="ru"><trans-title>Клиницист</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8338</issn><issn publication-format="electronic">2412-8775</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">219</article-id><article-id pub-id-type="doi">10.17650/1818-8338-2012-6-2-50-53</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE PREVALENCE OF ARTERIAL HYPERTENSION AND THE SPECIFIC FEATURES OF DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN RADIATION-EXPOSED PERSONS</article-title><trans-title-group xml:lang="ru"><trans-title>РАСПРОСТРАНЕННОСТЬ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ И ОСОБЕННОСТИ ФОРМИРОВАНИЯ ГИПЕРТРОФИИ МИОКАРДА ЛЕВОГО ЖЕЛУДОЧКА У ЛИЦ, ПОДВЕРГШИХСЯ РАДИАЦИОННОМУ ОБЛУЧЕНИЮ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kukushkin</surname><given-names>S. K.</given-names></name><name xml:lang="ru"><surname>Кукушкин</surname><given-names>С. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Evidence-Based Medicine</p></bio><bio xml:lang="ru"><p>кафедра доказательной медицины</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Martynchik</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Мартынчик</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Manoshkina</surname><given-names>E. M.</given-names></name><name xml:lang="ru"><surname>Маношкина</surname><given-names>Е. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Hospital Therapy Department One, Medical Faculty</p></bio><bio xml:lang="ru"><p>кафедра госпитальной терапии № 2 лечебного факультета</p></bio></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kharitonov</surname><given-names>A. Yu.</given-names></name><name xml:lang="ru"><surname>Харитонов</surname><given-names>А. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shamarin</surname><given-names>V. M.</given-names></name><name xml:lang="ru"><surname>Шамарин</surname><given-names>В. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff6"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Research Center of Preventive Medicine, Ministry of Health of Russia, Moscow</institution></aff><aff><institution xml:lang="ru">ФГБУ «Государственный научно-исследовательский центр профилактической медицины» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University, Moscow</institution></aff><aff><institution xml:lang="ru">МГМУ им. И.М. Сеченова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">НИИ общественного здоровья и управления здравоохранением Первого МГМУ им. И.М. Сеченова</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Research Institute of Public Health and Health Care Management, I.M. Sechenov First Moscow State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБУ «Государственный научно-исследовательский центр профилактической медицины» Минздрава России&#13;
МГМСУ</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">State Research Center of Preventive Medicine, Ministry of Health of Russia, Moscow&#13;
Moscow State University of Medicine and Dentistry, Moscow</institution></aff><aff><institution xml:lang="ru">ФГБУ «Государственный научно-исследовательский центр профилактической медицины» Минздрава России</institution></aff></aff-alternatives><aff id="aff6"><institution>State Research Center of Preventive Medicine, Ministry of Health of Russia, Moscow</institution></aff><pub-date date-type="pub" iso-8601-date="2012-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2012</year></pub-date><volume>6</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>50</fpage><lpage>53</lpage><history><date date-type="received" iso-8601-date="2015-10-16"><day>16</day><month>10</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-10-16"><day>16</day><month>10</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, Kukushkin S.K., Martynchik E.A., Manoshkina E.M., Kharitonov A.Y., Shamarin V.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Кукушкин С.К., Мартынчик Е.А., Маношкина Е.М., Харитонов А.Ю., Шамарин В.М.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">Kukushkin S.K., Martynchik E.A., Manoshkina E.M., Kharitonov A.Y., Shamarin V.M.</copyright-holder><copyright-holder xml:lang="ru">Кукушкин С.К., Мартынчик Е.А., Маношкина Е.М., Харитонов А.Ю., Шамарин В.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://klinitsist.abvpress.ru/Klin/article/view/219">https://klinitsist.abvpress.ru/Klin/article/view/219</self-uri><abstract xml:lang="en"><p>Moscow Aim – to study the prevalence of arterial hypertension (AH) and left ventricular hypertrophy among male liquidators (ML) of Chernobyl accident consequences and a group of unorganized males (UM) from one of the Moscow regions. Materials and methods. The results of examining a random representative sample of three hundred and ninety-five 35–64-year-old Mos-cow Registry MLs of Chernobyl accident consequences (n = 395; 79 % response rate) were analyzed. A random sample of males from one of the Moscow regions (n = 382; 70 % response rate) was used to make up an age-matched comparison group.Results. The age-adjusted prevalence rate (AAPR) of AH according to the expanded WHO criteria (&gt; 140/90 Hg mm) was substantially higher among MLs than among UMs (64.9 and 54.7 %, respectively; p &lt; 0.01). The prevalence of AH was associated with the men’s age in both populations. Thus, this among MLs and UMs in the 35–44 year age group was 54.6 and 47.2 %, respectively and in the 55–64 year age group 80 and 62.2 % (i.e. the incidence of AH increased by 1.3 (р &lt; 0.01) and 1.2 (р &lt; 0.05) times, respectively). Conclusion. AAPR of AH among the liquidators was significantly higher than that in the control group (64.9 % versus 54.7 %, respectively). In the compared groups, that of left ventricular hypertrophy did not differ and was 25 and 25.6 %, respectively; significant differences were found in the degree of left ventricular hypertrophy: certain (concentric) left ventricular hypertrophy was more common in the liquidators than in the comparison group (12.9 % versus 7.4 %, respectively). In the ML group compared to the control group, there was much higher awareness of having AH (59.1 % versus 46 %, respectively), drug treatment was performed in 38.7 % versus 7.9 %; effective BP control in the patients was 13.1 % versus 4.7 %, respectively.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>left ventricular hypertrophy</kwd><kwd>radiation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>гипертрофия миокарда левого желудочка</kwd><kwd>радиационное облучение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Kannel W.B. Prevalence and natural histori of electrocardiografhic left entricular hypertrophy. Am. J. Med. 1983;75:4–11.</mixed-citation><mixed-citation xml:lang="ru">Kannel W.B. Prevalence and natural histori of electrocardiografhic left entricular hypertrophy. Am. J. Med. 1983;75:4–11.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Verdecchia P., Schillaci G., Borgioni C. et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48–54.</mixed-citation><mixed-citation xml:lang="ru">Verdecchia P., Schillaci G., Borgioni C. et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48–54.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Шальнова С.А., Смоленский А.В., Шамарин В.М. и др. Артериальная гипертония и гипертрофия левого желудочка у ликвидаторов аварии на Чернобыльской АЭС. Кардиология 1998; 6: 48–50.</mixed-citation><mixed-citation xml:lang="ru">Шальнова С.А., Смоленский А.В., Шамарин В.М. и др. Артериальная гипертония и гипертрофия левого желудочка у ликвидаторов аварии на Чернобыльской АЭС. Кардиология 1998; 6: 48–50.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
